Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net income (loss)	$ 14,249,645	$ (5,655,119)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	10,724	18,384
Amortization	424,812	424,812
Lease expense (benefit)	15,870	(660)
Loss on disposal of property and equipment	135,600
Loss on operating lease right-of-use asset - lease abandonment	146,795
Loss on operating lease right-of-use asset - lease termination settlement	2,992
Stock-based compensation - employees	746,300	1,176,600
Stock-based compensation - non-employees	279,000	36,000
Shares issued related to lease termination settlement	50,700
Shares issued for interest	159,300	168,750
Non-cash services expense	19,000
Change in fair value of patent acquisition liability	660,000	(290,000)
Gain on derecognition of debt	(21,179,043)
Foreign exchange loss	55,210	65,724
Changes in operating assets and liabilities
Other receivable	310,111	(5,205)
Accounts payable	(2,507)	(36,009)
Accounts payable – related parties	8,347
Accrued interest – related and non-related parties	3,441,595	3,055,027
Accrued expenses	124,800	172,346
Net cash used in operating activities	(340,749)	(869,350)
Cash flows from investing activities
Loan to Emergence Global Enterprises Inc.	(17,901)
Advances to CEN Biotech Ukraine LLC	(114,000)	(190,000)
Proceeds from sale of equipment	1,801
Net cash used in investing activities	(130,100)	(190,000)
Cash flows from financing activities
Issuance of convertible notes	499,000	1,045,914
Repayment of convertible notes	(30,000)	(6,000)
Issuance of convertible notes - related parties		20,000
Net cash provided by financing activities	469,000	1,059,914
Net (decrease) increase in cash and cash equivalents	(1,849)	564
Cash and cash equivalents, beginning of year	3,757	3,193
Cash and cash equivalents, end of year	1,908	3,757
Supplemental cash flows disclosures
Cash paid for interest	75,963	85,847
Non-cash transactions - investing and financing activities
Issuance of note payable for services	19,000
Issuance of common stock - settlement of accrued liability	$ 58,500